Article
mTOR regulates vascular smooth muscle cell differentiation from human bone marrow-derived mesenchymal progenitors.
Arteriosclerosis, thrombosis, and vascular biology - 1 Feb 2009
Hegner Björn, Lange Maria, Kusch Angelika, Essin Kirill, Sezer Orhan, Schulze-Lohoff Eckhard, Luft Friedrich C, Gollasch Maik, Dragun Duska
Abstract excerpt
OBJECTIVE: Vascular smooth muscle cells (VSMCs) and circulating mesenchymal progenitor cells (MSCs) with a VSMC phenotype contribute to neointima formation and lumen loss after angioplasty and during allograft arteriosclerosis. We hypothesized that phosphoinositol-Akt-mammalian target of rapamycin-p70S6 kinase (PI3K/Akt/mTOR/p70S6K) pathway activation regulates VSMC differentiation from MSCs. METHODS AND RESULTS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
